From Practical Dermatology

Eight biologic drugs (not to mention three biosimilars) are currently approved to treat psoriasis and there is a greater understanding within the medical community that this disease goes more than skin deep. We are nearing a tipping point, but even with all this progress, still more is needed to improve the quality of life for the 7.5 million people in the United States who live with this disease.

Practical Dermatology┬« asked some thought leaders to share what they wish for to further advance care of these patients.

READ THE FULL ARTICLE from Practical Dermatology.